Table 1.
Patient baseline characteristics and clinical presentations following development of TACO.
| Patient Characteristics | Overall (n = 71) |
|---|---|
| Sex – n (%) | |
| Female – n (%) | 40 (56.3) |
| Male – n (%) | 31 (43.7) |
| Race – n (%) | |
| American Indian or Alaska Native | 1 (1.4) |
| Asian | 19 (26.8) |
| Black or African American | 3 (4.2) |
| White or Caucasian | 33 (46.5) |
| Other or Unknown | 15 (21.1) |
| Age – median (IQR) | 62.0 (51.0, 69.8) |
| Age ≧ 65 years – n (%) | 28 (39.4) |
| Any High Risk Comorbidities – n (%) | 54 (76.1) |
| Congestive Heart Failure | 16 (22.5) |
| Coagulopathy | 47 (66.2) |
| Renal Failure | 18 (25.4) |
| Organ Transplant | 24 (33.8) |
| Blood Transfusion Product Type and Volume | |
| Multiple Blood Product Types – n (%) | 49 (69.0) |
| RBC + Platelets | 31 (43.7) |
| RBC + Platelets + Plasma | 14 (19.7) |
| Platelets + Plasma | 2 (2.8) |
| RBC + Plasma | 1 (1.4) |
| RBC + Platelets + Plasma + Cryoprecipitate | 1 (1.4) |
| Single Blood Product Type – n (%) | 22 (31.0) |
| RBC | 14 (19.7) |
| Platelets | 6 (8.5) |
| Plasma | 2 (2.8) |
| Transfusion Volume (mL) – median (IQR) | 1262.5 (558.3, 2540.8) |
| Transfusion Unit – median (IQR) | 4.6 (2.0, 9.5) |
| TACO Management | |
| Any Fluid management - n (%) | 63 (88.7) |
| Bumetanide | 4 (5.6) |
| Furosemide | 47 (66.2) |
| Combination of pharmacological therapies | 7 (9.9) |
| Hemodialysis | 7 (9.9) |
| Any Oxygen Device – n (%) | 57 (80.3) |
| Oxygen Device FIO2 – median (IQR) | 100 (100, 100) |
| Ventilator – n (%) | 8 (11.3) |
| Hospital Service | |
| General Surgery | 3 (4.2) |
| Hospital Medicine | 13 (18.3) |
| Liver Transplant | 7 (9.9) |
| Malignant Hematology | 34 (47.9) |
| Neurosurgery | 5 (7.0) |
| Other | 9 (12.7) |
| Laboratory Measures – median (IQR) | |
| B-type natriuretic peptide (pg/mL) (n = 38) | 396.0 (177, 1270.0) |
| Systolic Blood Pressure (mmHg) | 159.5 (141.8, 182.8) |
| Diastolic Blood Pressure (mmHg) | 81.0 (70.5, 94.8) |
| Body Temperature (°F) | 100.9 (99.3, 102.6) |
| Body Temperature ≧ 100.4 °F – n (%) | 41 (57.7) |
| Chest X-Ray Radiology Score (n= 20) | 3.0 (3.0, 3.0) |
| Weight Changes (L) | +1.35 (+0.2, +4.0) |